HLTH305: Pharmaceutical Puzzle

12345678910111213141516
Across
  1. 2. A set of rights granted by a government that gives the patent holder the exclusive right to make and sell an invention.
  2. 5. According to Fierlbeck, there is a creeping of ____ of health care in Canada as drugs are increasingly prescribed, as costs increase, and as outpatient treatment is emphasized.
  3. 7. The rules, processes, and structures that are put in place by governments and public agencies to manage problems related to the availability of medicines and the role of medicine in health care.
  4. 8. Abbreviation for what is issued if Health Canada approves the submission and is allowed to sell the drug in Canada.
  5. 9. Regulator of drugs for safety, efficacy and quality in several stages throughout their development and after they are put onto the market. (two words)
  6. 10. Government responsible for intellectual property rights of manufacturers (patents) and the initial approval and labelling of prescription drugs and for ensuring overall market competitiveness.
  7. 11. The role of the federal government: _____, price, and patent regulation.
  8. 14. Drug costs following a national pharmacare program.
  9. 15. The way a drug works when used in the population is called.
  10. 16. The National Forum on Health called to establish this national program in 1997.
Down
  1. 1. The number of years a patent is typically valid.
  2. 2. Government responsible for funding of all health care services, including pharmaceuticals.
  3. 3. According to Fierlbeck, the two policy issues associated with pharmaceuticals ____ and politics.
  4. 4. The size and the ______ mobility of drug companies make regulation of the pharmaceutical industry extraordinarily difficult.
  5. 5. Any chemical substance formulated or compounded as single active ingredient or in combination of other active substances. (two words)
  6. 6. Abbreviation for what the manufacturer files to get authorization to sell the drug in Canada after a clinical trial shows that a drug has potential therapeutic value that outweighs the risks.
  7. 12. Canada allows two kinds of direct-to-consumer advertisements: ____ ads and disease-oriented or help-seeking ads.
  8. 13. They control what can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing.
  9. 16. Abbreviation for the publicly funded network of university-based experts from across Canada commited to conducting and communicating policy-relevant research with integrity.